Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression- an Asian Sub-group Analysis from the SUSTAIN-2 Study
- Resource Type
- Article
- Source
- 20. 1 (2022): 70-86.
- Subject
Administration intranasal Esketamine Asia Depressive disorder treatment-resistant Antidepressive agents - Language
- Korean
- ISSN
- 17381088